Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,284.21
+6.70(+0.13%)
Dow
38,581.86
-104.46(-0.27%)
Nasdaq
16,835.35
+100.34(+0.60%)
Bitcoin USD
69,245.83
+923.16(+1.35%)
CMC Crypto 200
1,499.31
+31.37(+2.14%)

BMY Jan 2025 35.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

7.25

0.00

(0.00%)

As of 02:58PM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....